Leerink Partners analyst Marc Goodman maintained a Buy rating on Johnson & Johnson (JNJ – Research Report) yesterday and set a price target ...

We recently published a list of Jim Cramer Discusses These 13 Stocks & Rejects The AI PC Super Cycle. In this article, we are ...

We recently published a list of 12 Safe Stocks to Buy for the Long Term in 2025. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other safe stocks to ...

Johnson & Johnson (NYSE:JNJ), a global healthcare giant, finds itself at a critical juncture as it navigates a complex landscape of opportunities and challenges. The company's recent performance and ...

When CP companies do innovate in 2025, they plan to focus on truly novel products rather than minor enhancements or changes ...

Johnson & Johnson (NYSE:JNJ), a global healthcare giant, continues to navigate a complex landscape of opportunities and ...

Johnson & Johnson is a holding company ... and MedTech. The Consumer Health segment includes products focused on personal healthcare used in the Skin Health/Beauty, Over-the-Counter medicines ...

In this edition of MILS Legal Surgery, Professor Henry Blair takes a close look at three big-ticket issues that dealers ...

Both these factors can be tied in part to J&J’s strong presence in the consumer ... products is a strong pharmaceutical backbone that has emerged over the company’s long and varied history ...

The principles of magic aren’t confined to the stage—they’re incredibly effective in the world of marketing as well.

Plus, Lodi Community Foundation lands a $30 million bequest, and the Ukrainian Catholic University Foundation gets millions ...

The state is a food science hub thanks to all the food company headquarters, including General Mills and Cargill.